SUBSTIPHARM
Philippe Beaupere has held various key roles in the pharmaceutical industry, with a focus on corporate development and business growth. With an academic background in pharmacy and marketing intelligence, Philippe has navigated through different companies such as Substipharm Limited, Biocodex, and Mercury Pharmaceuticals, gaining expertise in rebranding and business development. Currently, Philippe serves as the Chief Corporate Development Officer at SUBSTIPHARM and Managing Director at Vygoris Limited.
SUBSTIPHARM
Substipharm is a privately held pharmaceutical Group. We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects. We have a successful portfolio of pharmaceutical products and vaccines including: Mature brands Generics Over the counter (OTC) pharmaceuticals Difficult to develop medicines Value added presentations Biological products including vaccines: